Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 16Unknown 3Terminated 3Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 18Interventional 2

Sponsor

Conditions

Breast Neoplasms 1328Neoplasms 998Carcinoma, Non-Small-Cell Lung 865Prostatic Neoplasms 730Colorectal Neoplasms 671Lung Neoplasms 553Leukemia, Myeloid, Acute 475Neoplasm Metastasis 427Pancreatic Neoplasms 426Carcinoma, Hepatocellular 407Ovarian Neoplasms 393Multiple Myeloma 393Stomach Neoplasms 383Recurrence 369Squamous Cell Carcinoma of Head and Neck 327Melanoma 295Uterine Cervical Neoplasms 288Brain Neoplasms 288Triple Negative Breast Neoplasms 273Glioblastoma 263Head and Neck Neoplasms 260Precursor Cell Lymphoblastic Leukemia-Lymphoma 256Endometrial Neoplasms 238Lymphoma 230Esophageal Neoplasms 226Rectal Neoplasms 224Sarcoma 213Carcinoma, Renal Cell 205Colonic Neoplasms 196Lymphoma, Large B-Cell, Diffuse 194

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Interventional × Rare Diseases × Clear all
NCT06856902 2026-04-01

BEAMER

Technical University of Madrid

Phase NA Recruiting
3,100 enrolled

Treatment Adherence and Compliance, Cardiovascular Diseases, Neoplasms, Rare Diseases

NCT04760522 2023-11-29

GE-MED

University Hospital Tuebingen

Phase NA Recruiting
12,000 enrolled

Genetic Risk Score, Genetic Predisposition to Disease, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡